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Abstract
Differentiated vulvar intraepithelial neoplasia (dVIN) is the precursor lesion of HPV-negative vulvar squamous cell carcinoma
(VSCC). The histopathological diagnosis of dVIN can be challenging, as it often resembles vulvar non-neoplastic epithelial
disorders (NNED), especially lichen sclerosus (LS). We aimed to establish the most specific and reproducible histological
features of dVIN and assessed cytokeratin 13 (CK13) and cytokeratin 17 (CK17) immunohistochemistry as a diagnostic aid.
Consecutive cases of dVIN (n = 180) and LS (n = 105) from the period 2010 to 2013 were reviewed using a checklist of
histological features. Each feature was recorded as ‘present’ or ‘absent’ and statistical comparison (dVIN vs LS) was made.
Interobserver agreement between two pairs of pathologists was assessed for a subset of cases of dVIN (n = 31) and LS and other
NNED (n = 23). Immunohistochemistry with CK13, CK17, MIB1 and p53 was performed on dVIN, LS, and other NNED cases.
Macronucleoli, features of disturbed maturation and angulated nuclei were significantly more common in dVIN than LS (p <
0.001). We found ‘substantial agreement’ for the diagnosis of dVIN (κ = 0.71). Macronucleoli and deep keratinisation had the
highest agreement. In dVIN, the mean percentage of cells staining with CK13 was 15 and with CK17, this was 74. For LS, the
mean percentage of cells staining with CK13 was 31, and with CK17, this was 41. By plotting receiver operating characteristic
curves (ROC), an area under the curve (AUC) of 0.52 was obtained for CK13, and an AUC of 0.87 was obtained for CK17. The
most helpful histological features for diagnosing dVIN were macronucleoli, features of disturbed maturation, and angulated
nuclei. Increased CK17 expression may have promise for supporting dVIN diagnosis.
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Introduction
Vulvar intraepithelial neoplasia (VIN) is widely accepted as
the precursor lesion of vulvar squamous cell carcinoma
(VSCC) [1]. VSCC arises via either a human papilloma virus
(HPV)-associated pathway, or more commonly, via a mecha-
nism independent of HPV, often being linked to chronic in-
flammatory conditions such as lichen sclerosus (LS) [1, 2].
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Accordingly, two distinct subtypes of VIN are recognised: the
HPV-associated high-grade squamous intraepithelial lesion/
usual VIN (HSIL/uVIN) and the non-HPV-associated differ-
entiated VIN (dVIN) [1]. HSIL is clinically identified by its
multifocal, warty appearance and on histology by conspicuous
cytological and architectural atypia [2]. Differentiated VIN, on
the other hand, often produces ill-defined lesions, and on his-
tology, notoriously mimics non-neoplastic epithelial disorders
(NNED), particularly LS [1, 2]. As a result, dVIN is rarely (<
5% cases) identified in advance of a diagnosis of invasive
malignancy, despite being the precursor lesion of the majority
of VSCC [3]. Moreover, there is substantial interobserver var-
iability in the histological diagnosis of dVIN [4, 5]. In a recent
study amongst vulva pathology experts, ‘basal layer atypia’
was the only criterion that met consensus to be ‘essential’ for
dVIN diagnosis [6]. However, even this feature may not be
readily appreciable in every case. The histological features of
dVIN have been extensively described in the literature, but
they have not been quantified so far [2, 5, 7].
In order to aid this difficult histological diagnosis, immu-
nohistochemical markers p53 and MIB1 are commonly used,
but both have limitations for making the distinction from
NNED [2]. Increased p53 staining (overexpression) in the
basal and parabasal layers is seen in dVIN, as a reflection of
missense mutations of the TP53 gene [2]. Additionally, 25–
30% cases of dVIN show complete absence of p53 staining
(null pattern), due to nonsense mutations and deletions [8].
However, p53 overexpression also occurs in long-standing
LS and squamous hyperplasia, albeit as a consequence of
ischemic stress [9–13]. The proliferation marker MIB1 can
be increased in dVIN, as well as in NNED [14].
Recently, the diagnostic utility of the immunohistochemi-
cal markers cytokeratin 13 (CK13) and cytokeratin 17 (CK17)
has been established for oral epithelial dysplasia [15–17].
Loss of CK13 along with expression of CK17 has been re-
ported in (high-grade) oral epithelial dysplasia [15–17].
Increased expression of CK17 has been reported for dVIN
[14], but CK13 has not yet been explored for this lesion.
Through this study, we aimed to establish the histological
features of dVIN, which are most helpful to reliably distin-
guish dVIN from LS. The immunohistochemical markers,
CK13 and CK17, were evaluated as diagnostic adjuncts for
dVIN. To the best of our knowledge, this is the first study to
quantify the histological features of dVIN, and to assess both
CK13 and CK17 for dVIN diagnosis.
Materials and methods
Consecutive cases with a histological diagnosis of dVIN, LS,
other NNED (e.g. lichen simplex chronicus, lichenoid inflam-
mation, chronic non-specific inflammation, epithelial hyper-
plasia, hyperkeratosis) and VSCC, from the period 2010 to
2013 were identified from the electronic database of the
Department of Pathology, Erasmus MC. All the data were
anonymised. The slides of these cases were retrieved from
the archives.
Our study comprised three steps: histological evaluation,
reproducibility analysis and assessment of immunohistochem-
istry. All the cases of dVIN and LS that were identified were
included for the histological evaluation, and subsets of dVIN,
LS and NNED cases were used for the reproducibility and
immunohistochemistry analyses. The details of each step are
further elaborated below.
Histological evaluation
Histological evaluation was conducted on dVIN and LS,
which is the closest and most difficult differential of dVIN.
We formulated a checklist of histological features for dVIN
based on the literature [4, 5, 7]. The components of the check-
list are listed and described below. For all cases of dVIN and
LS, each of the features on the checklist was recorded as
‘present’ or ‘absent’. The statistical significance of each fea-
ture for the diagnosis of dVIN over LS was calculated.
Nuclear atypia This included variation in nuclear size and
shape, including angulated nuclei; abnormality of the nuclear
chromatin, i.e. hyperchromatic or open chromatin; presence of
macronucleoli, i.e. nucleoli visible at ×100 magnification and
multinucleation.
Mitoses The presence of suprabasal and/or atypical mitotic
figures was noted. The number of mitotic figures per 5 mm
of the epithelium was counted.
Disturbed maturation Disturbed maturation leads to prema-
ture keratinisation in the deeper layers of the epithelium,
which was identified by a hyper-eosinophilic appearance.
Individual cell keratinisation, deep keratinisation and deep
squamous eddies (abortive pearls of keratin) were recorded
as hallmarks of premature keratinisation. Cobblestone appear-
ance of the epithelium, which is a combination of premature
keratinisation with spongiosis, was recorded.
Architecture Elongated (and anastomosing) rete ridges were
noted.
Other features Hyperkeratosis, parakeratosis, sub-epithelial
hyalinisation and inflammatory cell infiltration were also
recorded.
Reproducibility
A representative subset of 54 cases were selected by two pa-
thologists, SDG and PEG. The set comprised 31 dVIN, 10 LS
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and 13 other NNED cases. The cases were deliberately select-
ed to provide a range of challenges. Thus, dVINwith classical
histological appearances, as well as dVIN with ambiguous
features, i.e. where the distinction between dVIN and LS
was more difficult, were included. Glass slides of these cases
were independently assessed by two other pathologists, SK
and VNH. They were asked to provide a diagnosis for each
case and adjudge the usefulness of the histological features for
their diagnosis. The clinical history of the cases was not pro-
vided. No consensus training preceded the study. The agree-
ment between the pathologists for (i) the overall diagnosis and
(ii) the presence of the individual histological features identi-
fied as most specific (from the checklist described above) was
measured.
Immunohistochemistry
Immunohistochemistry was conducted on a subset of cases of
dVIN, LS, and NNED. This set included cases found to have a
good agreement for their diagnoses amongst pathologists in
the reproducibility study and additional ones.
Sections of 4-μ thickness were prepared from formalin-
fixed paraffin-embedded (FFPE) tissue. Cytokeratin 13 (clone
KS-1A3, dilution 1:400, ThermoFisher); dual stain CK17-
MIB1 (clone SP-95, ready to use, Ventana) and p53 (BP53-
11, ready to use, Ventana) immunohistochemistry, with appro-
priate positive and negative controls, was carried out accord-
ing to manufacturer’s instructions on Benchmark Ultra
Immunostainer (Roche).
Defined areas adjudged to be dVIN were marked on the
HE-stained slides for accurate comparison with the slides
stained with immunohistochemistry. Immunohistochemistry
slides were scored by SDG, PEG and SK on a multi-head
microscope. The stains were analysed as described below.
CK13 and CK17 The percentage of cells showing cytoplasmic
staining; the intensity of staining (weak, moderate, and strong)
and their distribution in the epithelium was noted. Receiver
operating characteristic (ROC) curves were plotted for CK13
and CK17, using the percentage of cell stained, to assess their
individual sensitivity and specificity for dVIN diagnosis. In
order to assess whether these markers perform better when
interpreted together, another ROC curve was derived.
MIB1 Increased MIB1 expression was noted as more than
sporadic nuclear staining in the basal and/or suprabasal layers.
p53 Staining with p53 was recorded as overexpression, null
pattern or wild type. Intense nuclear staining in ≥ 50% cells in
the lower one third of the epithelium, occasionally extending
to the suprabasal layers was considered overexpression.
Nuclear staining of weak to moderate intensity, in < 50% cells
in the lower one third of epithelium was noted as wild type.
Complete absence of staining was noted as null pattern.
Statistical analysis
Data analysis was done with IBM SPSS Statistics 24 (SPSS,
Chicago, IL, USA). Independent sample’s t test was used for
parametric data and chi-square (χ2) test for non-parametric
data to deduce the p value. A p value < 0.05 was considered
statistically significant. Interobserver agreement was mea-
sured with Cohen’s kappa. Kappa (κ) was interpreted as <
0.20 = poor, 0.21–0.40 = fair, 0.41–0.60 = moderate, 0.61–
0.80 = substantial and 0.81–1.00 = almost perfect agreement.
Results
From the archives, 180 cases of dVIN, 105 cases of LS and
126 cases of NNED were identified. Of the 180 cases of
dVIN, 61 were isolated dVIN and 119 were identified next
to VSCC. Fifty-nine percent (36/61) of the isolated dVIN had
a history of VSCC. For histological evaluation, 180 cases of
dVIN and 105 cases of LS were included.
Histological evaluation
Nuclear atypia All cases of dVIN showed nuclear atypia, al-
beit in varying extents. Some variation in nuclear size and
shape could be noticed under low magnification (×100) in
63% (114/180) of dVIN. Abnormalities of nuclear chromatin
(hyperchromatic or open chromatin) were present in all dVIN
cases. Angulated nuclei, seen in 66% (119/180) of dVIN, and
macronucleoli, seen in 65% (118/180) of dVIN had the stron-
gest statistical significance (p < 0.001).
Mitoses Atypical mitoses and suprabasal mitoses were noted
more frequently than a mitotic count > 5/5 mm in dVIN.
Disturbed maturation Individual cell keratinisation was pres-
ent in 92% (165/180), deep keratinisation in 78% (141/180)
and deep squamous eddies in 61% (110/180) of dVIN cases.
Cobblestone appearance of the epithelium was noted in 83%
(149/180) of dVIN cases. All of these features had strong
statistical significance for dVIN (p < 0.001).
Architecture Elongated rete ridges were present in 63% (114/
180) of dVIN (p < 0.01) and appeared to be anastomosing in
20% (37/180) of cases.
Other features Parakeratosis was noted in 73% (132/180) of
dVIN (p < 0.01). An overview of the histological evaluation is
given in Table 1, and the histological features are illustrated in
Figs. 1 and 2.
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Reproducibility
We found ‘substantial’ interobserver agreement (κ = 0.71, stan-
dard error (SE) = 0.11, 95% confidence interval (CI) 0.51–0.95)
on the selected subset of cases for the diagnosis of dVIN. Out of
all the histological features evaluated from the checklist, sub-
stantial agreement was obtained for macronucleoli (κ = 0.75),
deep keratinisation (κ = 0.71), deep squamous eddies (ĸ =
0.68), individual cell keratinisation (κ = 0.66), mitotic count
> 5/5 mm (κ = 0.64) and angulated nuclei (ĸ = 0.60). The his-
tological features with substantial and ‘moderate’ agreement are
listed in Table 1 of the Supplementary Material.
Immunohistochemistry
Immunohistochemistry with p53, CK13 and dual-stain CK17-
MIB1 was conducted on an initial set of 24 cases of dVIN, 9
cases of LS and 8 cases of NNED. For further evaluation of
CK13 and CK17, these stains were carried out on an addition-
al set comprising 30 cases of dVIN, 5 cases of LS and 22 cases
of NNED.
Cytokeratin 13
For LS and other NNED cases, the percentage of cells staining
with CK13 was higher compared to dVIN, and the staining
intensity was stronger (Fig. 3).
Differentiated VIN (n = 54) In 15% (8/54) of dVIN, there was a
complete lack of CK13 staining. Patchy, weak staining in the
suprabasal layers was seen in 67% (36/54); and diffuse, weak
staining in the superficial layers was seen in 18% (10/54). The
mean percentage of cells positive for CK13was 15 (95%CI =
9.4–20.5).
Table 1 Evaluation of
histological features (dVIN vs
LS)
Histological features dVIN (n = 180) LS (n = 105) p value
(dVIN vs LS)Number (percentage) Number
(percentage)
A. Nuclear atypia
Obvious under low power (×100) 114 (63) 0 0.01
Angulated nuclei 119 (66) 8 (8) 0.001
Chromatin pattern
- Open 96 (53) 6 (6) 0.01
- Hyperchromatic 84 (47) 10 (10) 0.01
Macronucleoli 118 (65) 24 (23) 0.001
Multinucleation 129 (72) 65 (62) 0.20
B. Mitotic figures
Mitotic count > 5/5 mm 67 (37) 20 (19) 0.003
Atypical mitoses 102 (57) 0 < 0.001
Suprabasal mitoses 122 (68) 13 (12) < 0.01
C. Disturbed maturation
Individual cell keratinisation 165 (92) 21 (20) < 0.001
Deep keratinisation 141 (78) 4 (4) < 0.001
Deep eddies 110 (61) 0 < 0.001
Cobblestone appearance 149 (83) 12 (11) 0.001
D. Architecture
Elongated rete ridges 114 (63) 7 (7) 0.01
- Elongated and anastomosing 37 (21) 0 0.01
E. Others
Inflammatory response
- Scanty/focal 41 (23) 17 (16)
- Moderate 82 (46) 51 (49) 0.25
- Marked 57 (32) 37 (35)
Sub-epithelial hyalinisation 124 (69) 81(77) 0.10
Hyperkeratosis 125 (69) 77 (73) 0.58
Parakeratosis 132 (73) 56 (53) 0.009
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Lichen sclerosus (n = 14) None of the LS cases showed com-
plete lack of CK13 staining. In 79% (11/14), diffuse staining
of moderate intensity was noted in the suprabasal layers; and
in 21% (3/14), patchy staining of moderate intensity was not-
ed in the suprabasal layers. The mean percentage of cells pos-
itive for CK13 was 31 (95% CI = 11.4–50).
NNED (n = 30) Complete lack of CK13 staining was also not
seen in any of the NNED cases. In 57% (17/30) of cases,
diffuse staining of moderate intensity was noted in the
suprabasal layers; in 43% (13/30), patchy staining ofmoderate
intensity was noted in the suprabasal layers. The mean per-
centage of cells positive for CK13 was 39 (95% CI = 23.6–
53.8).
Cytokeratin 17
For dVIN, the percentage of cells staining with CK17 was
higher compared to LS and other NNED cases, and staining
intensity was stronger (Fig. 3).
Differentiated VIN (n = 54) Diffuse, strong staining, across the
full thickness of the epithelium was seen in 33% (18/54). The
rest of the dVIN showed diffuse, moderate to strong staining
in the suprabasal layers in 56% (30/54) of cases, and patchy,
strong staining in the superficial layers in 11% (6/54) of cases.
The mean percentage of cells positive for CK17 was 74 (95%
CI = 68.5–81.2).
Lichen sclerosus (n = 14) None of the cases of LS showed
diffuse, strong staining across full epithelial thickness.
Patchy, weak staining in the suprabasal layers was seen in
64% (9/14), and diffuse, weak staining in the superficial layers
in 36% (5/14). The mean percentage of cells positive for
CK17 was 41 (95% CI = 18.4–51.6).
NNED (n = 30) Complete absence of CK17 staining was noted
in 57% (17/30) of NNED cases. Patchy, weak staining in the
suprabasal layers was seen in 27% (8/30), and diffuse, weak
staining in the superficial layers was seen in 16% (5/30). The
mean percentage of cells positive for CK17was 19 (95%CI =
7.8–31.1).
Fig. 1 Example of differentiated VIN with characteristic features (HE
stain), low magnification appearance (a, b), with corresponding higher
magnification images (c, d). a Awidened epithelium with parakeratosis
and elongated rete ridges is seen. Nuclear atypia, premature keratinisation
and cobblestone appearance are apparent (original magnification ×50). b
Elongated rete ridges, a deep squamous eddy, nuclear atypia, and
parakeratosis can be identified under low magnification (original
magnification ×50). c Under higher magnification, macronucleoli can
be seen. Angulated nuclei, individual cell keratinisation and
cobblestone appearance (circled area) can be better appreciated (original
magnification ×100). d Atypical cells with both open chromatin and
hyperchromatic patterns are seen. There is cobblestone appearance
(circled area) and individual cell keratinisation (original magnification
×100)
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On computing ROC curves, CK13 had an area under
the curve (AUC) of 0.52 (SE 0.06, 95% CI = 0.40–0.64),
while CK17 had an AUC of 0.87 (SE 0.04, 95% CI =
0.80–0.94). The combination of both stains, i.e. when
CK13 and CK17 immunohistochemistry was interpreted
together, showed an AUC of 0.76, (SE 0.05, 95% CI =
0.70–0.87) (Fig. 4).
MIB1
Increased MIB1 was noted in 67% (36/54) dVIN, 36% (5/14)
LS, and 47% (14/30) other NNED cases; the details are elab-
orated in Table 2 of the Supplementary Material.
p53
Differentiated VIN (n = 24)Overexpression of p53 was seen in
45% (11/24), null pattern in 13% (3/24), and wild-type expres-
sion in 42% (10/24). Cases with null pattern and overexpres-
sion of p53 were considered positive for dVIN (Fig. 3).
Lichen sclerosus (n = 9) None of the cases of LS showed the
‘null pattern’. Overexpression of p53 was seen in 33% (3/9)
and wild-type expression in 67% (6/9) of LS cases (Fig. 3).
NNED (n = 8) All the NNED cases had wild-type p53 expres-
sion. The details of p53 expression are elaborated in Table 3 of
the Supplementary Material.
Fig. 3 Immunohistochemistry in differentiated VIN (a–d) and Lichen
sclerosus (e–h). a Differentiated VIN, HE stain b Overexpression of
p53. c Weak, patchy CK13 staining. d Strong and diffuse CK17
expression, with increased MIB-1. e Lichen sclerosus, HE stain. f Wild-
type p53 expression. g Diffuse staining of moderate intensity with CK13.
h Very weak, patchy CK17 staining with increased MIB-1
Fig. 2 Example of differentiated VIN with relatively subtle histological
features (HE stain). aNuclear atypia cannot be easily discerned under low
magnification (in contrast to Fig. 1a, c). A widened epithelium,
parakeratosis, some elongation of rete ridges and mildly increased
cellularity are seen (original magnification ×50). b Under higher
magnification, nuclear atypia with open chromatin pattern,
macronucleoli, individual cell keratinisation and cobblestone
appearance are detectable (original magnification ×100)
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Discussion
Differentiated VIN was first recognised as a precursor lesion
of VSCC in 1961 [2]. Over the years, a plethora of descriptive
terminology (e.g. vulvar dystrophy/hyperplasia with atypia)
led to incorrect categorisation of this lesion. Recent studies
report that the non-HPVrelated pathway contributes to around
80% of all VSCC [1, 2]. However, dVIN comprises only 2–
29% of standalone VIN diagnoses [2, 18–20]. This implies
that dVIN may be under-recognised, underlining the need for
well-defined diagnostic criteria.
Clinically, dVIN is known to present with vague grey-
white discoloration [2–5], on the background of long-
standing LS, and shows subtle histological features, which
are often difficult to distinguish from LS. However, dVIN is
known to progress rapidly to invasive carcinoma, with a re-
portedmedian interval of 28months [5, 18, 21]. Thus, dVIN is
often only recognised on histology adjacent to VSCC or on
follow-up biopsies. Literature describes the presence of dVIN
next to VSCC in up to 40% of cases [21]. In our study, dVIN
was identified next to 49% of VSCC cases.
To facilitate the reliable diagnosis of dVIN, we set out to
quantify its individual histological features. We found that
nuclear atypia, the sine qua non for dVIN diagnosis, could
be discerned under low power in only 63% of cases.
Amongst the components of nuclear atypia, macronucleoli
and angulated nuclei were the most specific. Both these fea-
tures had substantial interobserver agreement in terms of rel-
evance for a dVIN diagnosis. They can therefore be useful to
discriminate the nuclear atypia of dVIN from the reactive
nuclear enlargement seen in LS and other NNED.
Abnormality of the nuclear chromatin was noted in all dVIN
cases, with hyperchromatic or an open chromatin pattern oc-
curring with almost equal frequency. A mitotic count of > 5/
5 mm and atypical mitoses, although specific for dVIN, were
seen less frequently. Multinucleation, a common feature of
dVIN, was also seen regularly in LS and other NNED cases
and thus lacked statistical significance for dVIN diagnosis.
Disturbed maturation in the form of premature
keratinisation in the basal or parabasal layers is a morpholog-
ical reflection of the underlying pathology. Manifestations of
disturbed maturation (individual cell keratinisation, deep
keratinisation and deep eddies) were commonly noted in
dVIN. The features of disturbed maturation had the second
highest level of agreement amongst our pathologists, next in
importance only to macronucleoli for dVIN diagnosis.
Cobblestone appearance of the epithelium [22], elongated (±
anastomosing) rete ridges and parakeratosis could also be re-
producibly identified, and these features should be regarded as
important pointers towards the diagnosis of dVIN, especially
in cases where nuclear atypia cannot be easily discerned.
Spongiotic changes of the epithelium seen in NNED should
not be mistaken for the cobblestone appearance, as the latter is
always accompanied by evidence of disturbed maturation. We
found individual cell keratinisation, deep keratinisation, cob-
blestone appearance and parakeratosis to occur more frequent-
ly than suprabasal mitosis or abnormal mitotic figures in
dVIN. With this study, we hope to highlight the importance
of detailed scrutiny of these supporting features.
We noticed that dVIN can show a whole spectrum of mor-
phological features. However, even in the most subtle cases
with minimal nuclear atypia, alteration of cellularity and
Fig. 4 ROC curves for CK13 and
CK17 immunohistochemistry for
the diagnosis of dVIN. The green
line represents CK17 and the blue
line represents CK13, when they
are interpreted individually. The
yellow line represents the ROC
curve when CK13 and CK17 are
interpreted together. Area under
the curve (AUC) for CK13 =
0.52, CK17 = 0.87 and CK13 and
CK17 combined = 0.76
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alignment of nuclei with individual cell keratinisation and
parakeratosis are present. A link between the particulars of the
histological appearance and progression to VSCC could poten-
tially be explored. This detailed description and quantification
of the morphological features is primarily intended to guide the
general pathologist to recognise dVIN, particularly in the dubi-
ous cases where the difference from LS may not be apparent.
Immunohistochemistry with p53 and MIB1 is often used to
support the diagnosis of dVIN. However, no universal cutoff
exist for the interpretation of these stains, and thus, the distinc-
tion between wild-type p53 expression and p53 overexpression
may not be easy to make. We found the p53 null pattern to be
specific for dVIN, but only a minority of dVIN show this pat-
tern. A proportion of both dVIN and LS showed wild-type
expression and utility of p53 can be limited in these cases.
The second step of this studywas to evaluate CK13 andCK17
as potential diagnostic adjuncts for dVIN. Cytokeratins are cell
type-specific intermediate filament proteins and their expression
is altered in abnormalities of cellular differentiation. Expression
patterns of cytokeratins 8, 10, 13 and 14 in VSCCwere studied in
1995 by Ansink et al. [23]. They noted CK13 expression in well-
differentiated VSCC, as well as in the normal epithelium of labi-
umminus. Recently, there has been a lot of interest in cytokeratin
research, particularly for (high-grade) oral dysplasia.
Cytokeratin 13 is expressed physiologically from the prick-
le cell layer (third basal layer) to the keratinised layer (surface)
in normal oral mucosa [24, 25]. Progressive loss of CK13with
increasing grades of dysplasia has been demonstrated in the
oral cavity, cervix and oesophagus [25–32]. Cytokeratin 17 is
a basal/myoepithelial cell keratin which is not expressed under
physiological conditions in oral mucosa or perianal skin [16,
33, 34]. Increased CK17 expression has been reported in oral,
cervical and anal intraepithelial neoplasia [17, 31, 33, 34].
There is little information about CK17 expression in normal
vulvar tissue. In dVIN, increased CK17 expression has been
reported on in a single study [14].
We found CK13 expression to be lower in dVIN compared to
LS and other NNED. On the other hand, CK17 expression was
higher in dVIN than in LS and other NNED. From analysing the
ROC curves, increased CK17 expression showed better sensitiv-
ity and specificity than CK13 loss for dVIN. Similar to the find-
ings of Podoll et al. [14], diffuse CK17 staining across full epi-
thelial thickness or in the suprabasal layers was found to be
strongly supportive of a dVIN diagnosis. Complete lack of
CK13 staining was specific for dVIN, but this occurred in only
15% of cases. In some cases, CK17 immunohistochemistry may
be equivocal, for example, patchy, strong staining or diffuse
staining in the superficial layers only. In this situation, a reduced
expression or a complete lack of CK13 staining can offer addi-
tional support for the diagnosis of dVIN.
Our study, in common with most retrospective studies, has
some limitations; a selection bias cannot be ruled out. For testing
the reproducibility, a limited number of cases selected by two
pathologists was included, and the two other participants were
experienced pathologists from the same institute. Thus, our re-
sults may not entirely reflect daily diagnostic practice. External
validation studies, with more cases and participants from other
centres will follow.With respect to immunohistochemistry, more
extensive research on the expression of CK17 in vulvar skin and
mucosa is necessary to establish its relevance in practice.
Despite the limitations, we have attempted to describe here the
most helpful histological features to enable the diagnosis of
dVIN. Increased CK17 expression has potential as a diagnostic
adjunct for dVIN and deserves further exploration in this context.
Conclusion
Macronucleoli and angulated nuclei should alert the patholo-
gist to consider the diagnosis of dVIN. Disturbed maturation
and cobblestone appearance are other specific and reproduc-
ible features of dVIN and may be of particular use where
nuclear atypia is less prominent. Increased CK17 expression
may have promise as an adjunct to histology for discriminat-
ing dVIN from close differentials.
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